Premium
Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient
Author(s) -
Douglass J. A.,
Carroll K.,
Voskamp A.,
Bourke P.,
Wei A.,
O’Hehir R. E
Publication year - 2010
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.2009.02259.x
Subject(s) - omalizumab , systemic mastocytosis , medicine , anaphylaxis , citation , anaphylactic reactions , allergy , pediatrics , dermatology , immunology , library science , immunoglobulin e , mast cell , antibody , computer science